UniProtKB/Swiss-Prot O60449: Variant p.Lys1321Asn

Lymphocyte antigen 75
Gene: LY75
Feedback?

Variant information Variant position:

1321 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Lysine (K) to Asparagine (N) at position 1321 (K1321N, p.Lys1321Asn). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from large size and basic (K) to medium size and polar (N) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs12692566 [ dbSNP | Ensembl ]

Sequence information Variant position:

1321 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

1722 The length of the canonical sequence.
Location on the sequence:

QLLYFNYMASWVMLGITYRN K SLMWFDKTPLSYTHWRAGRP The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         QLLYFNYMASWVMLGITYRNKSLMWFDKTPLSYTHWRAGRP

Mouse                         QLLYFNYIASWVMLGITYENNSLMWFDKTALSYTHWRTGRP

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	28 – 1722	Lymphocyte antigen 75
Topological domain	28 – 1666	Extracellular
Domain	1251 – 1374	C-type lectin 8
Glycosylation	1320 – 1320	N-linked (GlcNAc...) asparagine
Helix	1319 – 1321

Literature citations
cDNA cloning of human DEC-205, a putative antigen-uptake receptor on dendritic cells.
Kato M.; Neil T.K.; Clark G.J.; Morris C.M.; Sorg R.V.; Hart D.N.J.;
Immunogenetics 47:442-450(1998)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4); VARIANT ASN-1321; Hodgkin's lymphoma cell lines express a fusion protein encoded by intergenically spliced mRNA for the multilectin receptor DEC-205 (CD205) and a novel C-type lectin receptor DCL-1.
Kato M.; Khan S.; Gonzalez N.; O'Neill B.P.; McDonald K.J.; Cooper B.J.; Angel N.Z.; Hart D.N.J.;
J. Biol. Chem. 278:34035-34041(2003)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3); TISSUE SPECIFICITY; VARIANT ASN-1321;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.